Epigenetic Reversion of Breast Carcinoma Phenotype Is Accompanied by Changes in DNA Sequestration as Measured by AluI Restriction Enzyme
- 1 May 2007
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 170 (5) , 1739-1749
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (EY10457, DEAC03-76SF0098)
- U.S. Department of Energy (EY10457, DEAC03-76SF0098)
- Kreftforeningen (EY10457, DEAC03-76SF0098)
This publication has 47 references indexed in Scilit:
- Chromatin Organization Measured by AluI Restriction Enzyme Changes with Malignancy and Is Regulated by the Extracellular Matrix and the CytoskeletonThe American Journal of Pathology, 2005
- DNA methylation control of tissue polarity and cellular differentiation in the mammary epitheliumExperimental Cell Research, 2004
- cAMP effector mechanisms. Novel twists for an ‘old’ signaling systemFEBS Letters, 2003
- Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progressionEuropean Journal of Cancer, 2002
- The fibronectin isoform containing the ed‐b oncofetal domain: A marker of angiogenesisInternational Journal of Cancer, 1994
- Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissuesInternational Journal of Cancer, 1994
- Migration stimulating activity in serum of breast cancer patientsThe Lancet, 1991
- Wounding and Its Role in RSV-Mediated Tumor FormationScience, 1985
- Inability of Rous sarcoma virus to cause sarcomas in the avian embryoNature, 1984
- Resistance of chinese hamster ovary cell chromatin to endonuclease digestionExperimental Cell Research, 1983